An integrated general practice and pharmacy-based intervention to promote the prescription and use of appropriate preventive medications among individuals at high cardiovascular risk.

综合全科实践和基于药学的干预措施，以促进心血管高危人群处方和使用适当的预防药物。

• 批准号: nhmrc : GNT1084657
• 负责人: A/Pr Bandana Saini
• 金额: $ 229.64万
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2015
• 资助国家: 澳大利亚
• 起止时间: 2015-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/an-integrated-general-cardiovascular-risk/1345573
• 关键词: integrated; general; practice; pharmacy; based

We will conduct a randomised controlled trial that combines three methods to reduce risk factors and improve outcomes for people with cardiovascular disease (CVD). The methods include administration of a polypill, a GP-focused point-of-care intervention, and a pharmacy-led intervention to improve commencement and persistence with taking medications. We expect that integrating these three approaches will lead to large reductions in CVD risk factor levels for participants.

我们将进行一项随机对照试验，结合三种方法来减少心血管疾病（CVD）患者的风险因素并改善其预后。这些方法包括给予复方制剂，以GP为重点的护理点干预，以及以药房为主导的干预，以改善服药的开始和持续性。我们预计，整合这三种方法将导致参与者的CVD风险因素水平大幅降低。